Back

Addressing the unmet needs in LDL-c lowering: what can we expect?

26 August 2022 (13:20 - 13:35)
Organised by:
Congress Presentation Part of: A decade of innovation, guidelines and paradigm shifts in LDL-C management (10th annual symposium) Lipid-Lowering Agents Open Access ESC Congress 2022

About the speaker

Photo
Professor John Kastelein

Academic Medical Centre, Amsterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Introduction: changing paradigms in LDL-c reduction.
Professor K. Ray (London, GB)
Slides Video
Presentation thumbnail
LDC-c: new insights into its role as causal risk factor and target for therapy
Professor B. Ference (Cambridge, GB)
Slides Video
Presentation thumbnail
Targeting the PCSK9 pathway: where do novel therapies fit in?
Associate Professor A. Navar (Dallas, US)
Slides Video
Presentation thumbnail
Discussion.
Professor K. Ray (London, GB)
Slides Video

Access the full session

Session thumbnail
A decade of innovation, guidelines and paradigm shifts in LDL-C management (10th annual symposium)
Video

The Event

Event poster

ESC Congress 2022

26 August 2022 13:20 CET
You may be interested in
thumbnail
Congress Session
Role of CETP inhibitors in cardiovascular risk reduction: will lessons from the past lead to future success?
27 August 2023
thumbnail
Congress Presentation
New treatment options for LDL cholesterol.
27 August 2022
thumbnail
Congress Presentation
Novel oral LDL-c lowering therapies on the horizon: CETP inhibition
1 September 2024
thumbnail
Congress Presentation
Patients with high LDL cholesterol: early combination therapy.
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources